33416111|t|Melatonin inhibits RANKL-induced osteoclastogenesis through the miR-882/Rev-erbalpha axis in Raw264.7 cells.
33416111|a|Melatonin, secreted in a typical diurnal rhythm pattern, has been reported to prevent osteoporosis; however, its role in osteoclastogenesis remains unclear. In the present study, the ability of melatonin to inhibit receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis and the associated mechanism were investigated. Raw264.7 cells were cultured with RANKL (100 ng/ml) and macrophage colony-stimulating factor (M-CSF; 30 ng/ml) for 7 days, and tartrate-resistant acid phosphatase (TRAP) staining was used to detect osteoclastogenesis following treatment with melatonin. In addition, the effect of melatonin on cathepsin K and microRNA (miR)-882 expression was investigated via western blotting and reverse transcription-quantitative PCR. Melatonin significantly inhibited RANKL-induced osteoclastogenesis in Raw264.7 cells. From bioinformatics analysis, it was inferred that nuclear receptor subfamily 1 group D member 1 (NR1D1/Rev-erbalpha) may be a target of miR-882. In vitro, melatonin upregulated Rev-erbalpha expression and downregulated miR-882 expression in the osteoclastogenesis model. Rev-erbalpha overexpression boosted the anti-osteoclastogenesis effects of melatonin, whereas miR-882 partially diminished these effects. The present results indicated that the miR-882/Rev-erbalpha axis may serve a vital role in inhibiting osteoclastogenesis following RANKL and M-CSF treatment, indicating that Rev-erbalpha agonism or miR-882 inhibition may represent mechanisms through which melatonin prevents osteoporosis.
33416111	0	9	Melatonin	Chemical	MESH:D008550
33416111	19	24	RANKL	Gene	21943
33416111	64	71	miR-882	Gene	100124461
33416111	72	84	Rev-erbalpha	Gene	217166
33416111	93	101	Raw264.7	CellLine	CVCL:0493
33416111	109	118	Melatonin	Chemical	MESH:D008550
33416111	195	207	osteoporosis	Disease	MESH:D010024
33416111	303	312	melatonin	Chemical	MESH:D008550
33416111	324	374	receptor activator of nuclear factor-kappaB ligand	Gene	21943
33416111	376	381	RANKL	Gene	21943
33416111	458	466	Raw264.7	CellLine	CVCL:0493
33416111	492	497	RANKL	Gene	21943
33416111	585	620	tartrate-resistant acid phosphatase	Gene	11433
33416111	622	626	TRAP	Gene	11433
33416111	700	709	melatonin	Chemical	MESH:D008550
33416111	738	747	melatonin	Chemical	MESH:D008550
33416111	751	762	cathepsin K	Gene	13038
33416111	767	785	microRNA (miR)-882	Gene	100124461
33416111	879	888	Melatonin	Chemical	MESH:D008550
33416111	913	918	RANKL	Gene	21943
33416111	949	957	Raw264.7	CellLine	CVCL:0493
33416111	1016	1061	nuclear receptor subfamily 1 group D member 1	Gene	217166
33416111	1063	1068	NR1D1	Gene	217166
33416111	1069	1081	Rev-erbalpha	Gene	217166
33416111	1102	1109	miR-882	Gene	100124461
33416111	1121	1130	melatonin	Chemical	MESH:D008550
33416111	1143	1155	Rev-erbalpha	Gene	217166
33416111	1185	1192	miR-882	Gene	100124461
33416111	1237	1249	Rev-erbalpha	Gene	217166
33416111	1312	1321	melatonin	Chemical	MESH:D008550
33416111	1331	1338	miR-882	Gene	100124461
33416111	1414	1421	miR-882	Gene	100124461
33416111	1422	1434	Rev-erbalpha	Gene	217166
33416111	1506	1511	RANKL	Gene	21943
33416111	1549	1561	Rev-erbalpha	Gene	217166
33416111	1573	1580	miR-882	Gene	100124461
33416111	1631	1640	melatonin	Chemical	MESH:D008550
33416111	1650	1662	osteoporosis	Disease	MESH:D010024
33416111	Positive_Correlation	MESH:D008550	217166
33416111	Association	MESH:D010024	217166
33416111	Association	MESH:D010024	100124461
33416111	Negative_Correlation	MESH:D008550	21943
33416111	Association	100124461	217166
33416111	Negative_Correlation	MESH:D008550	100124461
33416111	Negative_Correlation	MESH:D008550	MESH:D010024
33416111	Association	100124461	21943

